Mamaling, Policarpio, JR.. I.
HRN: 07-17-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2025
METRONIDAZOLE 500MG (TAB)
05/06/2025
05/12/2025
PO
1 1/2tab
TID
AGE Sec To Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes